The correlation between skeletal muscle index and anxiety in patients with lung cancer on the first day of chemotherapy

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J. Clin. 72(1), 7–33 (2022).
  MedlineGoogle Scholar
• 2. Iyer S, Roughley A, Rider A, Taylor-Stokes G. The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study. Support. Care Cancer 22(1), 181–187 (2014).
  MedlineGoogle Scholar
• 3. Gil F, Costa G, Hilker I, Benito L. First anxiety, afterwards depression: psychological distress in cancer patients at diagnosis and after medical treatment. Stress Health 28(5), 362–367 (2012).
  MedlineGoogle Scholar
• 4. Morrison EJ, Novotny PJ, Sloan JA et al. Emotional problems, quality of life, and symptom burden in patients with lung cancer. Clin. Lung Cancer 18(5), 497–503 (2017).
  MedlineGoogle Scholar
• 5. Yan X, Chen X, Li M, Zhang P. Prevalence and risk factors of anxiety and depression in Chinese patients with lung cancer: a cross-sectional study. Cancer Manag. Res. 11, 4347–4356 (2019).
  MedlineGoogle Scholar
• 6. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann. Oncol. 18(9), 1437–1449 (2007).
  MedlineGoogle Scholar
• 7. Fearon K, Strasser F, Anker SD et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 12(5), 489–495 (2011).
  MedlineGoogle Scholar
• 8. Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur. J. Cancer 57, 58–67 (2016).
  MedlineGoogle Scholar
• 9. Bye A, Sjøblom B, Wentzel-Larsen T et al. Muscle mass and association to quality of life in non-small cell lung cancer patients. J. Cachexia Sarcopenia Muscle 8(5), 759–767 (2017). • Demonstrated that skeletal muscle index levels were correlated with quality of life in patients with lung cancer before starting chemotherapy.
  MedlineGoogle Scholar
• 10. Roeland EJ, Bohlke K, Baracos VE et al. Management of cancer cachexia: ASCO guideline. J. Clin. Oncol. 38(21), 2438–2453 (2020).
  Medline CASGoogle Scholar
• 11. Yang M, Shen Y, Tan L, Li W. Prognostic value of sarcopenia in lung cancer: a systematic review and meta-analysis. Chest 156(1), 101–111 (2019).
  MedlineGoogle Scholar
• 12. Soares JDP, Gomes TLN, Siqueira JM et al. Muscle function loss is associated with anxiety in patients with gastrointestinal cancer. Clin. Nutr. ESPEN 29, 149–153 (2019). •• Indicates that muscle function loss is related to anxiety in cancer patients.
  MedlineGoogle Scholar
• 13. Nipp RD, Fuchs G, El-Jawahri A et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist 23(1), 97–104 (2018). • Emphasizes a correlation between sarcopenia and quality of life in lung cancer patients.
  MedlineGoogle Scholar
• 14. Pasco JA, Williams LJ, Jacka FN et al. Sarcopenia and the common mental disorders: a potential regulatory role of skeletal muscle on brain function? Curr. Osteoporos. Rep. 13(5), 351–357 (2015).
  MedlineGoogle Scholar
• 15. Maes M, Ruckoanich P, Chang YS, Mahanonda N, Berk M. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 35(3), 769–783 (2011).
  Medline CASGoogle Scholar
• 16. Mousavi K, Jasmin BJ. BDNF is expressed in skeletal muscle satellite cells and inhibits myogenic differentiation. J. Neurosci. 26(21), 5739–5749 (2006).
  Medline CASGoogle Scholar
• 17. Kim A, Chung KC, Keir C, Patrick DL. Patient-reported outcomes associated with cancer screening: a systematic review. BMC Cancer 22(1), 223 (2022).
  MedlineGoogle Scholar
• 18. Iscan G, Cetin B, Kilic F, Kalayci H, Kalayci A, Iscan SC. Investigation of anxiety sensitivity levels of cancer patients in terms of COVID-19 vaccine: a cross-sectional study. Support. Care Cancer 30(5), 4139–4147 (2022).
  MedlineGoogle Scholar
• 19. Taghizadeh N, Tremblay A, Cressman S et al. Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort. BMJ Open 9(1), e024719 (2019).
  MedlineGoogle Scholar
• 20. Cetkin HE, Tuna A. How does health education given to lung cancer patients before thoracotomy affect pain, anxiety, and respiratory functions? J. Cancer Educ. 34(5), 966–972 (2019).
  MedlineGoogle Scholar
• 21. Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale–Anxiety (HADS-A). Arthritis Care Res. (Hoboken) 63(Suppl. 11(0 11)), S467–S472 (2011). • Gives important information regarding the State-Trait Anxiety Inventory in cancer patients.
  MedlineGoogle Scholar
• 22. Yasin AI, Topcu A, Shbair AT et al. Anxiety levels of breast cancer patients in Turkey during the COVID-19 pandemic. Future Oncol. 17(25), 3373–3381 (2021).
  CASGoogle Scholar
• 23. Chabowski M, Polański J, Jankowska-Polańska B, Janczak D, Rosińczuk J. Is nutritional status associated with the level of anxiety, depression and pain in patients with lung cancer? J. Thorac. Dis. 10(4), 2303–2310 (2018).
  MedlineGoogle Scholar
• 24. Tang H, Chen L, Wang Y, Zhang Y, Yang N, Yang N. The efficacy of music therapy to relieve pain, anxiety, and promote sleep quality, in patients with small cell lung cancer receiving platinum-based chemotherapy. Support. Care Cancer 29(12), 7299–7306 (2021).
  MedlineGoogle Scholar
• 25. Mattsson S, Olsson EMG, Carlsson M, Johansson BBK. Identification of anxiety and depression symptoms in patients with cancer: comparison between short and long web-based questionnaires. J. Med. Internet Res. 21(4), e11387 (2019).
  MedlineGoogle Scholar
• 26. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl. Physiol. Nutr. Metab. 33(5), 997–1006 (2008). • Comprehensive overview of CT images of the L3 vertebra in cancer patients.
  MedlineGoogle Scholar
• 27. Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer 19(1), 943 (2019).
  MedlineGoogle Scholar
• 28. Brown LF, Kroenke K, Theobald DE, Wu J, Tu W. The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psychooncology 19(7), 734–741 (2010).
  MedlineGoogle Scholar
• 29. Jittla P, Graham DM, Zhou C et al. EPIC: an evaluation of the psychological impact of early-phase clinical trials in cancer patients. ESMO Open 7(5), 100550 (2022).
  Medline CASGoogle Scholar
• 30. Boyes AW, Girgis A, D'Este C, Zucca AC. Flourishing or floundering? Prevalence and correlates of anxiety and depression among a population-based sample of adult cancer survivors 6 months after diagnosis. J. Affect. Disord. 135(1–3), 184–192 (2011).
  MedlineGoogle Scholar
• 31. Wang X, Ma X, Yang M et al. Proportion and related factors of depression and anxiety for inpatients with lung cancer in China: a hospital-based cross-sectional study. Support. Care Cancer 30(6), 5539–5549 (2022). • Highlights the high incidence of anxiety in lung cancer patients.
  MedlineGoogle Scholar
• 32. Syrjala KL, Sutton SK, Jim HS et al. Cancer and treatment distress psychometric evaluation over time: a BMT CTN 0902 secondary analysis. Cancer 123(8), 1416–1423 (2017).
  MedlineGoogle Scholar
• 33. McGovern J, Dolan RD, Horgan PG, Laird BJ, McMillan DC. Computed tomography-defined low skeletal muscle index and density in cancer patients: observations from a systematic review. J. Cachexia Sarcopenia Muscle 12(6), 1408–1417 (2021).
  MedlineGoogle Scholar
• 34. Howlader N, Forjaz G, Mooradian MJ et al. The effect of advances in lung-cancer treatment on population mortality. N. Engl. J. Med. 383(7), 640–649 (2020).
  Medline CASGoogle Scholar
• 35. Sjøblom B, Grønberg BH, Benth J et al. Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer. Lung Cancer 90(1), 85–91 (2015).
  MedlineGoogle Scholar
• 36. Pamoukdjian F, Bouillet T, Lévy V, Soussan M, Zelek L, Paillaud E. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review. Clin. Nutr. 37(4), 1101–1113 (2018).
  MedlineGoogle Scholar
• 37. Keogh JW, MacLeod RD. Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: a systematic review. J. Pain Symptom Manage. 43(1), 96–110 (2012).
  MedlineGoogle Scholar
• 38. Carvalho AF, Maes M, Solmi M et al. Is dynapenia associated with the onset and persistence of depressive and anxiety symptoms among older adults? Findings from the Irish longitudinal study on ageing. Aging Ment. Health 25(3), 468–475 (2021).
  MedlineGoogle Scholar
• 39. Alston H, Burns A, Davenport A. Loss of appendicular muscle mass in haemodialysis patients is associated with increased self-reported depression, anxiety and lower general health scores. Nephrology (Carlton) 23(6), 546–551 (2018).
  Medline CASGoogle Scholar
• 40. Breen SJ, Baravelli CM, Schofield PE, Jefford M, Yates PM, Aranda SK. Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy? Med. J. Aust. 190(Suppl. 7), S99–S104 (2009).
  MedlineGoogle Scholar
• 41. Bergerot CD, Mitchell HR, Ashing KT, Kim Y. A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments: effects of age and gender. Support. Care Cancer 25(6), 1897–1904 (2017).
  MedlineGoogle Scholar
• 42. Polański J, Chabowski M, Chudiak A et al. Intensity of anxiety and depression in patients with lung cancer in relation to quality of life. Adv. Exp. Med. Biol. 1023, 29–36 (2018).
  Medline CASGoogle Scholar
• 43. Yang S, Xu X. Anxiety and quality of life among papillary thyroid cancer patients awaiting final pathology results after surgery. Endocrine 76(2), 377–384 (2022).
  Medline CASGoogle Scholar
• 44. Vodermaier A, Linden W, MacKenzie R, Greig D, Marshall C. Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br. J. Cancer 105(12), 1814–1817 (2011).
  Medline CASGoogle Scholar
• 45. Chabowski M, Polański J, Jankowska-Polanska B, Lomper K, Janczak D, Rosinczuk J. The acceptance of illness, the intensity of pain and the quality of life in patients with lung cancer. J. Thorac. Dis. 9(9), 2952–2958 (2017).
  MedlineGoogle Scholar
• 46. Die Trill M. Anxiety and sleep disorders in cancer patients. EJC Suppl. 11(2), 216–224 (2013).
  MedlineGoogle Scholar
• 47. Mei Hsien CC, Wan Azman WA, Md Yusof M, Ho GF, Krupat E. Discrepancy in patient-rated and oncologist-rated performance status on depression and anxiety in cancer: a prospective study protocol. BMJ Open 2(5), e001799 (2012).
  MedlineGoogle Scholar